Double-Blind Study of Miglitol in Japanese With type2 Diabetes

September 25, 2006 updated by: Sanwa Kagaku Kenkyusho Co., Ltd.
To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Japan
      • Aichi, Japan
      • Chiba, Japan
      • Fukuoka, Japan
      • Gunma, Japan
      • Hiroshima, Japan
      • Hyogo, Japan
      • Ibaragi, Japan
      • Ishikawa, Japan
      • Iwate, Japan
      • Kumamoto, Japan
      • Kyoto, Japan
      • Mie, Japan
      • Miyagi, Japan
      • Nagasaki, Japan
      • Niigata, Japan
      • Oita, Japan
      • Okayama, Japan
      • Osaka, Japan
      • Saga, Japan
      • Saitama, Japan
      • Shiga, Japan
      • Shimane, Japan
      • Shizuoka, Japan
      • Tokyo, Japan
      • Toyama, Japan
      • Yamagata, Japan
      • Yamaguchi, Japan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 69 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Type2 diabetic patient on Dietary Therapy
  • Criteria for postprandial plasma glucose and HbA1c are met

Exclusion Criteria:

  • Type1 diabetes
  • Patients treated with antidiabetic drugs or Insulin

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sanwa Kagaku Kenkyusho Co., Ltd.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted

September 25, 2006

First Submitted That Met QC Criteria

September 25, 2006

First Posted (ESTIMATE)

September 27, 2006

Study Record Updates

Last Update Posted (ESTIMATE)

September 27, 2006

Last Update Submitted That Met QC Criteria

September 25, 2006

Last Verified

September 1, 2006

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MG1001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus

Clinical Trials on miglitol

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe